Author:
Breslin Tara M.,Hess Kenneth R.,Harbison Dana B.,Jean Marina E.,Cleary Karen R.,Dackiw Alan P.,Wolff Robert A.,Abbruzzese James L.,Janjan Nora A.,Crane Christopher H.,Vauthey J. Nicolas,Lee Jeffrey E.,Pisters Peter W. T.,Evans Douglas B.
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 1987;59:2006?10.
2. Kalser MH, Ellenberg SS. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985; 120: 899?903.
3. Yeo CJ, Abrams RA, Grochow LB, et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg 1997; 225: 621?33.
4. Klinkenbijl JH, Jeekel J, Sahmoud T, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC Gastrointestinal Tract Cooperative Group. Ann Surg 1999; 230: 776?82.
5. Neoptlemos J, Dunn J, Moffitt D, et al. ESPAC-1 interim results: a European, randomized study to assess the roles of adjuvant chemotherapy (5FU+folinic acid) and adjuvant chemoradiation (40 Gy+5FU) in resectable pancreatic cancer. Proc Am Soc clin Oncol 2000; 19: 238(abstract).